Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3680)
All Articles published online
|
Sep 14, 2009 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lakatos PL. Prevalence, predictors, and clinical consequences of medical adherence in IBD: How to improve it? World J Gastroenterol 2009; 15(34): 4234-4239 [PMID: 19750566 DOI: 10.3748/wjg.15.4234] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i34/4234.htm |
| Number | Citing Articles |
| 1 |
Mingshi Chen, Caihong Yuan, Tianshu Xu. An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2020; 44(3): 302 doi: 10.1016/j.clinre.2019.07.003
|
| 2 |
Amosy E. MʼKoma, Erin H. Seeley, Mary K. Washington, David A. Schwartz, Roberta L. Muldoon, Alan J. Herline, Paul E. Wise, Richard M. Caprioli. Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides. Inflammatory Bowel Diseases 2011; 17(4): 875 doi: 10.1002/ibd.21442
|
| 3 |
Ayesha Akbar, Ian Arnott, Nicholas A Kennedy, Jonathan Nolan, Simon Peake, Simon R Whiteoak, Chris Probert, Aileen Fraser, Alex Cheshire, Allyson Lewis, Kathleen Sugrue, Susan Laird, Glyn Scott. Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitis. Gastrointestinal Nursing 2022; 20(1): 34 doi: 10.12968/gasn.2022.20.1.34
|
| 4 |
Cristina Bucci, Fabiana Zingone, Stella Tammaro, Paola Iovino, Antonella Santonicola, Carolina Ciacci. Factors Predicting the Adherence to the Therapy of Italian IBD Patients. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/6719345
|
| 5 |
Kellyn Moran, Kyle Null, Zhongwen Huang, Trevor Lissoos, Sunanda Kane. Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases. Advances in Therapy 2019; 36(9): 2260 doi: 10.1007/s12325-019-01037-x
|
| 6 |
Luca Morganti, Antonio Ascolese, Annabel Zettl, Lucia Pannese. Developing serious games to improve children’s compliance in chronic illnesses: Input from two use cases. Digital Medicine 2019; 5(1): 30 doi: 10.4103/digm.digm_2_19
|
| 7 |
Stéphane Nahon, Pierre Lahmek, Catherine Saas, Christelle Durance, Alain Olympie, Bruno Lesgourgues, Jean-Pierre Gendre. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients. Inflammatory Bowel Diseases 2011; 17(6): 1270 doi: 10.1002/ibd.21482
|
| 8 |
Firas Rinawi, Amit Assa, Corina Hartman, Yael Mozer Glassberg, Vered Nachmias Friedler, Yoram Rosenbach, Ari Silbermintz, Noam Zevit, Raanan Shamir. Evolution of disease phenotype in pediatric-onset Crohn’s disease after more than 10 years follow up—Cohort study. Digestive and Liver Disease 2016; 48(12): 1444 doi: 10.1016/j.dld.2016.08.118
|
| 9 |
Ashwin N Ananthakrishnan, Emily L McGinley, Kia Saeian. Length of Office Visits for Gastrointestinal Disease: Impact of Physician Specialty. American Journal of Gastroenterology 2010; 105(8): 1719 doi: 10.1038/ajg.2010.172
|
| 10 |
Danielle Huisman, Taylor Burrows, Louise Sweeney, Kirsty Bannister, Rona Moss-Morris. ‘Symptom-free’ when inflammatory bowel disease is in remission: Expectations raised by online resources. Patient Education and Counseling 2024; 119: 108034 doi: 10.1016/j.pec.2023.108034
|
| 11 |
Thiago H. Freitas, Thomas N. Hyphantis, Elias Andreoulakis, João Quevedo, Hesley L. Miranda, Gilberto S. Alves, Marcellus H. Souza, Lúcia L. Braga, Kenneth I. Pargament, Joanna K. Soczynska, Roger S. McIntyre, André F. Carvalho. Religious coping and its influence on psychological distress, medication adherence, and quality of life in inflammatory bowel disease. Brazilian Journal of Psychiatry 2015; 37(3): 219 doi: 10.1590/1516-4446-2014-1507
|
| 12 |
Weiguang Sun, Erna Li, Xin Mao, Yulin Zhang, Quxing Wei, Zhiyun Huang, Anfeng Wan, Yuxiao Zou, Udai P. Singh. The oligosaccharides of Xiasangju alleviates dextran sulfate sodium-induced colitis in mice by inhibiting inflammation. PLOS ONE 2023; 18(12): e0295324 doi: 10.1371/journal.pone.0295324
|
| 13 |
Mirjam Severs, Peter N. P. A. Zuithoff, Marie-Josée J. Mangen, Mirthe E. van der Valk, Peter D. Siersema, Herma H. Fidder, Bas Oldenburg. Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(9): 2158 doi: 10.1097/MIB.0000000000000853
|
| 14 |
Marin de Jong, Andrea van der Meulen-de Jong, Mariëlle Romberg-Camps, Juliette Degens, Marco Becx, Tineke Markus, Henny Tomlow, Mia Cilissen, Nienke Ipenburg, Marthe Verwey, Laurence Colautti-Duijsens, Wim Hameeteman, Ad Masclee, Daisy Jonkers, Marieke Pierik. Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD. Inflammatory Bowel Diseases 2017; 23(4): 485 doi: 10.1097/MIB.0000000000001034
|
| 15 |
Susanna Jäghult, Fredrik Saboonchi, Unn‐Britt Johansson, Regina Wredling, Marjo Kapraali. Identifying predictors of low health‐related quality of life among patients with inflammatory bowel disease: comparison between Crohn’s disease and ulcerative colitis with disease duration. Journal of Clinical Nursing 2011; 20(11-12): 1578 doi: 10.1111/j.1365-2702.2010.03614.x
|
| 16 |
Anisah Soobraty, Sarah Boughdady, Christian P Selinger. Current practice and clinicians’ perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians. World Journal of Gastrointestinal Pharmacology and Therapeutics 2017; 8(1): 67-73 doi: 10.4292/wjgpt.v8.i1.67
|
| 17 |
S. Ballou, W. Hirsch, P. Singh, V. Rangan, J. Nee, J. Iturrino, T. Sommers, J. Zubiago, N. Sengupta, A. Bollom, M. Jones, A. C. Moss, S. N. Flier, A. S. Cheifetz, A. Lembo. Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. Alimentary Pharmacology & Therapeutics 2018; 47(7): 913 doi: 10.1111/apt.14551
|
| 18 |
Sara Campos, Francisco Portela, Paula Sousa, Carlos Sofia. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era. European Journal of Gastroenterology & Hepatology 2016; 28(11): 1313 doi: 10.1097/MEG.0000000000000704
|
| 19 |
Mervat M. Alsous, Ahmed F. Hawwa, Cameron Imrie, Andras Szabo, Eman Alefishat, Rana Abu Farha, Mohammad Rwalah, Rob Horne, James C. McElnay. Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/9562192
|
| 20 |
Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, Chiara Mazzarella, Pierluigi Federico, Giusi Arboretto, Rossella D’Onofrio, Simone Olivieri, Giuseppe Zagaria, Tommaso Durante, Alessandro Federico. Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy. Brain-Apparatus Communication: A Journal of Bacomics 2023; 2(1) doi: 10.1080/27706710.2023.2181101
|
| 21 |
Robert J Basseri, Benjamin Basseri, Konstantinos A Papadakis. Dysplasia and cancer in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2011; 5(1): 59 doi: 10.1586/egh.10.77
|
| 22 |
Yu‐Jin Jeong, Da Hyun Kim, Kwang‐Won Lee. Homeostasis effects of fermented Maillard reaction products by Lactobacillus gasseri 4M13 in dextran sulfate sodium‐induced colitis mice. Journal of the Science of Food and Agriculture 2022; 102(1): 434 doi: 10.1002/jsfa.11374
|
| 23 |
Ashley Paige Duggan. The International Encyclopedia of Interpersonal Communication. 2015; : 1 doi: 10.1002/9781118540190.wbeic055
|
| 24 |
Gert Van Assche, Axel Dignass, Bernd Bokemeyer, Silvio Danese, Paolo Gionchetti, Gabriele Moser, Laurent Beaugerie, Fernando Gomollón, Winfried Häuser, Klaus Herrlinger, Bas Oldenburg, Julian Panes, Francisco Portela, Gerhard Rogler, Jürgen Stein, Herbert Tilg, Simon Travis, James O. Lindsay. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations. Journal of Crohn's and Colitis 2013; 7(1): 1 doi: 10.1016/j.crohns.2012.09.005
|
| 25 |
Riadh Jazrawi. Can more be done to optimise the effect of mesalazine for IBD patients with mild to moderate ulcerative colitis?. Gastrointestinal Nursing 2024; 22(Sup3): S1 doi: 10.12968/gasn.2024.22.Sup3.S1
|
| 26 |
Daniela Gilardi, Gionata Fiorino, Marco Genua, Mariangela Allocca, Silvio Danese. Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?. Expert Review of Gastroenterology & Hepatology 2014; 8(7): 835 doi: 10.1586/17474124.2014.917954
|
| 27 |
Hyesun Hyun, Seika Hashimoto-Hill, Myunghoo Kim, Michael D. Tsifansky, Chang H. Kim, Yoon Yeo. Succinylated Chitosan Derivative Has Local Protective Effects on Intestinal Inflammation. ACS Biomaterials Science & Engineering 2017; 3(8): 1853 doi: 10.1021/acsbiomaterials.7b00262
|
| 28 |
Cvetka Pernat Drobež, Katja Repnik, Mario Gorenjak, Ivan Ferkolj, Rinse K. Weersma, Uroš Potočnik. DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn’s disease. European Journal of Gastroenterology & Hepatology 2018; 30(4): 447 doi: 10.1097/MEG.0000000000001055
|
| 29 |
Simon R. Knowles, George Alex. Medication Adherence Across the Life Span in Inflammatory Bowel Disease. Gastroenterology Nursing 2020; 43(1): 76 doi: 10.1097/SGA.0000000000000467
|
| 30 |
Cvetka Pernat Drobež, Ivan Ferkolj, Uroš Potočnik, Katja Repnik. Crohn's Disease Candidate Gene Alleles Predict Time to Progression from Inflammatory B1 to Stricturing B2, or Penetrating B3 Phenotype. Genetic Testing and Molecular Biomarkers 2018; 22(3): 143 doi: 10.1089/gtmb.2017.0210
|
| 31 |
Kevin A. Hommel, Rachel N. Greenley, Michele Herzer Maddux, Wendy N. Gray, Laura M. Mackner. Self‐Management in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(2): 250 doi: 10.1097/MPG.0b013e3182999b21
|
| 32 |
|
| 33 |
Estée C.H. Feldman, Lindsay K. Durkin, Rachel Neff Greenley. Family Support is Associated with Fewer Adherence Barriers and Greater Intent to Adhere to Oral Medications in Pediatric IBD. Journal of Pediatric Nursing 2021; 60: 58 doi: 10.1016/j.pedn.2021.01.026
|
| 34 |
Mohammad Reza Ghadir, Mohammad Bagheri, Homayoon Vahedi, Nasser Ebrahimi Daryani, Reza Malekzadeh, Ahmad Hormati, Shadi Kolahdoozan, Meghedi Chaharmahali. Nonadherence to Medication in Inflammatory Bowel Disease: Rate and Reasons. Middle East Journal of Digestive Diseases 2016; 8(2): 116 doi: 10.15171/mejdd.2016.16
|
| 35 |
Mila Palma Pacheco, Flora Maria Lorenzo Fortes, Raquel Rocha dos Santos, Genoile Oliveira Santana Silva. Researching Interventions to Improve Medication Adherence in Ulcerative Colitis Patients. Journal of Coloproctology 2021; 41(01): 096 doi: 10.1055/s-0041-1724053
|
| 36 |
Eleni Vangeli, Savita Bakhshi, Anna Baker, Abigail Fisher, Delaney Bucknor, Ulrich Mrowietz, Andrew J. K. Östör, Laurent Peyrin-Biroulet, Ana P. Lacerda, John Weinman. A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases. Advances in Therapy 2015; 32(11): 983 doi: 10.1007/s12325-015-0256-7
|
| 37 |
D. R. Van Langenberg, P. R. Gibson. Systematic review: fatigue in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2010; 32(2): 131 doi: 10.1111/j.1365-2036.2010.04347.x
|
| 38 |
Ayesha Akbar, Ian Arnott, Nicholas A Kennedy, Jonathan Nolan, Simon Peake, Simon R Whiteoak, Chris Probert, Aileen Fraser, Alex Cheshire, Allyson Lewis, Kathleen Sugrue, Susan Laird, Glyn Scott. Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitis. British Journal of Hospital Medicine 2021; 82(10): 1 doi: 10.12968/hmed.2021.0399
|
| 39 |
Marin J de Jong, Andrea E van der Meulen-de Jong, Mariëlle J Romberg-Camps, Marco C Becx, Jeroen P Maljaars, Mia Cilissen, Ad A van Bodegraven, Nofel Mahmmod, Tineke Markus, Wim M Hameeteman, Gerard Dijkstra, Ad A Masclee, Annelies Boonen, Bjorn Winkens, Astrid van Tubergen, Daisy M Jonkers, Marie J Pierik. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. The Lancet 2017; 390(10098): 959 doi: 10.1016/S0140-6736(17)31327-2
|
| 40 |
Mark M.T.J. Broekman, Marieke J.H. Coenen, Geert J. Wanten, Corine J. van Marrewijk, Wietske Kievit, Olaf H. Klungel, André L.M. Verbeek, Dennis R. Wong, Piet M. Hooymans, Henk-Jan Guchelaar, Hans Scheffer, Luc J.J. Derijks, Marcel L. Bouvy, Dirk J. de Jong. Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases. European Journal of Gastroenterology & Hepatology 2018; 30(2): 167 doi: 10.1097/MEG.0000000000001025
|
| 41 |
Petra Weimers, Dorit Vedel Ankersen, Pia Munkholm. Biomarkers in Inflammatory Bowel Diseases. 2019; : 271 doi: 10.1007/978-3-030-11446-6_22
|
| 42 |
Fernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, Fabio Ayala, Vincenzo Bettoli, Luca Bianchi, Luca Cimino, Antonio Costanzo, Antonio Cristaudo, Salvatore D’Angelo, Marco Daperno, Anna Chiara Fostini, Mauro Galeazzi, Michele Gilio, Paolo Gionchetti, Paolo Gisondi, Ennio Lubrano, Antonio Marchesoni, Annamaria Offidani, Ambrogio Orlando, Daniela Pugliese, Carlo Salvarani, Raffaele Scarpa, Maurizio Vecchi, Giampiero Girolomoni. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease. Advances in Therapy 2018; 35(4): 545 doi: 10.1007/s12325-018-0672-6
|
| 43 |
Chen‐Ta Yang, Tsui‐Chun Hsu, Yang‐Yuan Chen, Siou‐Ping Huang, Hsu‐Heng Yen. Attitudes to medication and effects of IBD nursing service among patients with inflammatory bowel disease in Taiwan. Advances in Digestive Medicine 2024; doi: 10.1002/aid2.13383
|
| 44 |
Anna Bellizzi, Valentina Barucca, Daniela Fioriti, Maria T. Colosimo, Monica Mischitelli, Elena Anzivino, Fernanda Chiarini, Valeria Pietropaolo. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation. Journal of Cellular Physiology 2010; 224(2): 316 doi: 10.1002/jcp.22146
|
| 45 |
Lukas Schütz, Michael Radke, Stephan Menzel, Jan Däbritz. Long-term implications of structured transition of adolescents with inflammatory bowel disease into adult health care: a retrospective study. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1046-5
|
| 46 |
Riadh Jazrawi. Can more be done to optimise the effect of mesalazine for IBD patients with mild to moderate ulcerative colitis?. Gastrointestinal Nursing 2024; 22(Sup3a): S1 doi: 10.12968/gasn.2024.22.Sup3a.S1
|
| 47 |
Zhihui Li, Lili Qiao, Xiaojing Yun, Fangjuan Du, Shilei Xing, Maowu Yang. Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease. Zeitschrift für Gastroenterologie 2021; 59(02): 117 doi: 10.1055/a-1283-6966
|
| 48 |
Steven J Bernick, Sunanda Kane. Insight into the widespread problem of nonadherence to therapy in ulcerative colitis patients. Expert Review of Clinical Immunology 2010; 6(4): 677 doi: 10.1586/eci.10.28
|
| 49 |
Harry Kleinubing-Júnior, Mauro de S. L Pinho, Luis Carlos Ferreira, Guilherme Augusto Bachtold, Amanda Merki. Perfil dos pacientes ambulatoriais com doenças inflamatórias intestinais. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2011; 24(3): 200 doi: 10.1590/S0102-67202011000300004
|
| 50 |
Filippo Mocciaro, Roberto Di Mitri, Giuseppina Russo, Salvo Leone, Valerio Quercia. Motivational interviewing in inflammatory bowel disease patients: A useful tool for outpatient counselling. Digestive and Liver Disease 2014; 46(10): 893 doi: 10.1016/j.dld.2014.07.009
|
| 51 |
Andrew Lukas Yin, David Hachuel, John P Pollak, Ellen J Scherl, Deborah Estrin. Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review. Journal of Medical Internet Research 2019; 21(8): e14630 doi: 10.2196/14630
|
| 52 |
G. van Assche, A. Dignass, B. Bokemeyer, S. Danese, P. Gionchetti, G. Moser, L. Beaugerie, F. Gomollón, W. Häuser, K. Herrlinger, B. Oldenburg, J. Panes, F. Portela, G. Rogler, J. Stein, H. Tilg, S. Travis, J.O. Lindsay. Segundo consenso europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Parte 3: situaciones especiales (versión española). Revista de Gastroenterología de México 2015; 80(1): 74 doi: 10.1016/j.rgmx.2014.10.008
|
| 53 |
Rupa Banerjee, Partha Pal, Bhargavi Adigopula, Duvvuru Nageshwar Reddy. Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2021; 55(10): e92 doi: 10.1097/MCG.0000000000001480
|
| 54 |
Pascal Juillerat, Valérie Pittet, Christian Mottet, Christian Felley, Jean-Jacques Gonvers, John-Paul Vader, Bernard Burnand, Florian Froehlich, Frank L. Wolters, Reinhold W. Stockbrügger, Pierre Michetti. Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort. Scandinavian Journal of Gastroenterology 2010; 45(12): 1449 doi: 10.3109/00365521.2010.505660
|
| 55 |
Paula Sousa, Lorenzo Bertani, Cláudio Rodrigues. Management of inflammatory bowel disease in the elderly: A review. Digestive and Liver Disease 2023; 55(8): 1001 doi: 10.1016/j.dld.2022.12.024
|
| 56 |
Dóra Dohos, Alex Váradi, Nelli Farkas, Adrienn Erős, Andrea Párniczky, Eszter Schäfer, Éva Kosaras, Judit Czelecz, Péter Hegyi, Patrícia Sarlós. Hungarian Linguistic, Cross-Cultural, and Age Adaptation of the Patient Satisfaction with Health Care in Inflammatory Bowel Disease Questionnaire (CACHE) and the Medication Adherence Report Scale (MARS). Children 2022; 9(8): 1143 doi: 10.3390/children9081143
|
| 57 |
Hong-Hui Wang, Ying He, Hong-Xian Wang, Cheng-Ling Liao, Yu Peng, Li-Jian Tao, Wei Zhang, Hui-Xiang Yang. Comparison of <i>TPMT</i> and <i>NUDT15</i> polymorphisms in Chinese patients with inflammatory bowel disease. World Journal of Gastroenterology 2018; 24(8): 941-948 doi: 10.3748/wjg.v24.i8.941
|
| 58 |
Marin J. de Jong, Annelies Boonen, Andrea E. van der Meulen-de Jong, Mariëlle J. Romberg-Camps, Ad A. van Bodegraven, Nofel Mahmmod, Tineke Markus, Gerard Dijkstra, Bjorn Winkens, Astrid van Tubergen, Ad Masclee, Daisy M. Jonkers, Marie J. Pierik. Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial. Clinical Gastroenterology and Hepatology 2020; 18(8): 1744 doi: 10.1016/j.cgh.2020.04.038
|
| 59 |
Zohar Ben-Shatach, Tomer Ziv-Baran, Ella Fudim, Miri Yavzori, Orit Picard, Asaf Levartovsky, Limor Selinger, Batia Weiss, Uri Kopylov, Rami Eliakim, Bella Ungar. Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening. Therapeutic Advances in Gastroenterology 2022; 15: 175628482210833 doi: 10.1177/17562848221083395
|
| 60 |
Laurie Keefer, Tiffany H. Taft, Jennifer L. Kiebles. Handbook of Psychology, Second Edition. 2012; doi: 10.1002/9781118133880.hop209016
|
| 61 |
Laurie Keefer, Bethany Doerfler, Caroline Artz. Optimizing Management of Crohnʼs Disease Within a Project Management Framework: Results of A Pilot Study§. Inflammatory Bowel Diseases 2012; 18(2): 254 doi: 10.1002/ibd.21679
|